Improved survival using specialized multidisciplinary board in sarcoma patients.

Date publication

novembre 2017

Journal

Annals of oncology : official journal of the European Society for Medical Oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr KURTZ Jean-Emmanuel , Dr RIOS Maria

Tous les auteurs :
Blay JY, Soibinet P, Penel N, Bompas E, Duffaud F, Stoeckle E, Mir O, Adam J, Chevreau C, Bonvalot S, Rios M, Kerbrat P, Cupissol D, Anract P, Gouin F, Kurtz JE, Lebbe C, Isambert N, Bertucci F, Toumonde M, Thyss A, Piperno-Neumann S, Dubray-Longeras P, Meeus P, Ducimetière F, Giraud A, Coindre JM, Ray-Coquard I, Italiano A, Le Cesne A,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/29117335

Résumé

Sarcomas are rare but aggressive diseases. Specialized multidisciplinary management is not implemented for all patients in most countries. We investigated the impact of a multidisciplinary tumor board (MDTB) presentation before treatment in a nationwide study over 5 years.

Mots clés

Adolescent, Adult, Aged, Aged, 80 and over, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Recurrence, Local, mortality, Prognosis, Prospective Studies, Sarcoma, mortality, Soft Tissue Neoplasms, mortality, Survival Rate, Young Adult

Référence

Ann. Oncol.. 2017 Nov 1;28(11):2852-2859